PubRank

Benyi Li

Author PubWeight™ 25.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS One 2008 1.63
2 Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer. Endocrinology 2003 1.62
3 Proteasome inhibitors as potential novel anticancer agents. Drug Resist Updat 1999 1.56
4 Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. Mol Cancer Ther 2005 1.53
5 Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. Prostate 2007 1.28
6 Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer. Mol Cancer Ther 2003 1.26
7 Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824. Mol Cancer Ther 2005 1.24
8 Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer. Endocrinology 2004 1.22
9 Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer. Prostate 2007 1.14
10 GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagy and cell death. J Cell Sci 2010 1.12
11 Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care 2010 1.12
12 Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo. Prostate 2010 1.03
13 Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy. Anticancer Drugs 2012 0.96
14 Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling. Carcinogenesis 2009 0.96
15 Development of a peptide-drug conjugate for prostate cancer therapy. Mol Pharm 2011 0.92
16 Adeno-associated virus-delivered short hairpin-structured RNA for androgen receptor gene silencing induces tumor eradication of prostate cancer xenografts in nude mice: a preclinical study. Int J Cancer 2010 0.92
17 Prodrug strategy for PSMA-targeted delivery of TGX-221 to prostate cancer cells. Mol Pharm 2012 0.89
18 Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells. Prostate 2012 0.84
19 G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells. Prostate 2011 0.84
20 Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Prostate 2008 0.82
21 Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice. Nanomedicine (Lond) 2012 0.81
22 Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude mice. Prostate 2015 0.79
23 Down-regulation of amyloid-β through AMPK activation by inhibitors of GSK-3β in SH-SY5Y and SH-SY5Y-AβPP695 cells. J Alzheimers Dis 2012 0.78
24 The calcimimetic R-568 induces apoptotic cell death in prostate cancer cells. J Exp Clin Cancer Res 2009 0.76
25 HSP70 silencing combined with AIF: a novel therapeutic approach for cancer. Cancer Biol Ther 2009 0.75